Stock Research for RMD

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

RMD Stock Chart & Research Data

The RMD chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the RMD chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


RMD Due diligence Resources & Stock Charts

The RMD stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View RMD Detailed Price Forecast - CNN Money CNN View RMD Detailed Summary - Google Finance
Yahoo View RMD Detailed Summary - Yahoo! Finance Zacks View RMD Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View RMD Trends & Analysis - Trade-Ideas Barrons View RMD Major Holders - Barrons
NASDAQ View RMD Call Transcripts - NASDAQ Seeking View RMD Breaking News & Analysis - Seeking Alpha
Spotlight View RMD Annual Report - CompanySpotlight.com OTC Report View RMD OTC Short Report - OTCShortReport.com
TradeKing View RMD Fundamentals - TradeKing Charts View RMD SEC Filings - Bar Chart
WSJ View Historical Prices for RMD - The WSJ Morningstar View Performance/Total Return for RMD - Morningstar
MarketWatch View the Analyst Estimates for RMD - MarketWatch CNBC View the Earnings History for RMD - CNBC
StockMarketWatch View the RMD Earnings - StockMarketWatch MacroAxis View RMD Buy or Sell Recommendations - MacroAxis
Bullish View the RMD Bullish Patterns - American Bulls Short Pains View RMD Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View RMD Stock Mentions - StockTwits PennyStocks View RMD Stock Mentions - PennyStockTweets
Twitter View RMD Stock Mentions - Twitter Invest Hub View RMD Investment Forum News - Investor Hub
Yahoo View RMD Stock Mentions - Yahoo! Message Board Seeking Alpha View RMD Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for RMD - SECform4.com Insider Cow View Insider Transactions for RMD - Insider Cow
CNBC View RMD Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for RMD - OTC Markets
Yahoo View Insider Transactions for RMD - Yahoo! Finance NASDAQ View Institutional Holdings for RMD - NASDAQ


Stock Charts

FinViz View RMD Stock Insight & Charts - FinViz.com StockCharts View RMD Investment Charts - StockCharts.com
BarChart View RMD Stock Overview & Charts - BarChart Trading View View RMD User Generated Charts - Trading View




Latest Financial News for RMD


84% of people with asthma may be using their inhalers incorrectly, Propeller Health study finds
Posted on Thursday February 21, 2019

MADISON, Wis., Feb. 21, 2019 /PRNewswire/ -- The vast majority of people with asthma may be using their inhalers incorrectly, potentially making their medicine less effective and increasing their risk of asthma attacks, according to new research published in The Journal of Allergy and Clinical Immunology: In practice by digital therapeutics company Propeller Health, in partnership with the University of Colorado School of Medicine and Children's Hospital Colorado. Many asthma medicines require that patients take two "puffs" of their inhaler to receive the prescribed dose.


Fisher & Paykel, ResMed settle global patent disputes; shares jump
Posted on Wednesday February 20, 2019

New Zealand medical device maker Fisher & Paykel Healthcare Corp Ltd and U.S. rival ResMed Inc have agreed to settle patent infringement disputes, ending a three-year tussle that spanned the globe and cost each side millions of dollars in legal fees. In a joint statement on Thursday, the companies agreed to end all ongoing infringement cases and said neither would admit liability or make any payment. Fisher & Paykel shares were 6.9 percent higher after the announcement, reaching a more than four-month peak, whereas ResMed's Australian depository receipts were 1.1 percent firmer.


NZ's Fisher & Paykel and ResMed settle global patent disputes
Posted on Wednesday February 20, 2019

Medical device maker Fisher & Paykel Healthcare and U.S.-based ResMed on Thursday agreed to settle disputes over patent infringement, bringing to an end a tussle spanning the globe. The two companies had ...


ResMed and Fisher & Paykel Healthcare Announce Settlement of Global Patent Infringement Litigation
Posted on Wednesday February 20, 2019

ResMed (NYSE: RMD, ASX: RMD), and Fisher & Paykel Healthcare (NZX: FPH, ASX: FPH) today announced an agreement to settle all outstanding patent infringement disputes between the companies in all venues around the world. The settlement involves no payment or admission of liability by either side. “I am pleased we were able to resolve these disputes,” said ResMed CEO Mick Farrell.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.